This week, four medical devices stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Vermillion, Inc. (VRML) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. Vermillion engages in the discovery, development, and commercialization of diagnostics tests that help physicians to diagnose, treat, and improve outcomes for patients. Shares of the stock have been changing hands at an unusually rapid pace, three times the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of VRML stock.
Winner Medical Group (WWIN) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
This week, Antares Pharma, Inc.’s (ATRS) ratings are up from a C last week to a B. Antares Pharma develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. For more information, get Portfolio Grader’s complete analysis of ATRS stock.
Medtronic, Inc. (MDT) is seeing ratings go up from a C last week to a B this week. Medtronic develops therapeutic and diagnostic medical products. Shares of MDT have increased 6% over the past month, better than the 1.7% decrease the S&P 500 has seen over the same period of time. Shares of the stock have been changing hands at an unusually rapid pace, twice the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of MDT stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.